Type II transmembrane serine proteases

被引:92
作者
Szabo, R
Wu, QY
Dickson, RB
Netzel-Arnett, S
Antalis, TM
Bugge, TH
机构
[1] Natl Inst Dent & Craniofacial Res, Proteases & Tissue Remodeling Unit, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA
[2] Berlex Biosci, Richmond, CA USA
[3] Georgetown Univ, Med Ctr, Vincent T Lombardi Canc Res Ctr, Washington, DC 20007 USA
[4] Amer Red Cross, Jerome H Holland Lab Biomed Sci, Vasc Biol Dept, Rockville, MD USA
关键词
serine proteases; cell surface proteolysis; transmembrane;
D O I
10.1160/TH03-02-0071
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The recent availability of human and mouse genome sequences and expressed sequence tag databases facilitated the identification of a large new family of membrane anchored serine proteases, the type II transmembrane serine proteases or TTSPs. Analyses of human inherited disorders and gene targeting studies in mice have revealed that several members of this new protease family have critical functions in development and health. Preliminary studies also suggest that aberrant expression of type II transmembrane serine proteases may be linked to disease progression. The knowledge gathered thus far of the genetics, physiology, and pathology of this interesting new serine protease family will be reviewed here in brief.
引用
收藏
页码:185 / 193
页数:9
相关论文
共 82 条
[1]  
Adachi M, 2001, J AM SOC NEPHROL, V12, P1114, DOI 10.1681/ASN.V1261114
[2]  
Afar DEH, 2001, CANCER RES, V61, P1686
[3]   Novel mutations of TMPRSS3 in four DFNB8/B10 families segregating congenital autosomal recessive deafness [J].
Ben-Yosef, T ;
Wattenhofer, M ;
Riazuddin, S ;
Ahmed, ZM ;
Scot, HS ;
Kudoh, J ;
Shibuya, K ;
Antonarakis, SE ;
Bonne-Tamir, B ;
Radhakrishna, U ;
Naz, S ;
Ahmed, Z ;
Riazuddin, S ;
Pandya, A ;
Nance, WE ;
Wilcox, ER ;
Friedman, TB ;
Morell, RJ .
JOURNAL OF MEDICAL GENETICS, 2001, 38 (06) :396-400
[4]   Deregulated activation of matriptase in breast cancer cells [J].
Benaud, CM ;
Oberst, M ;
Dickson, RB ;
Lin, CY .
CLINICAL & EXPERIMENTAL METASTASIS, 2002, 19 (07) :639-649
[5]   MATRIX METALLOPROTEINASES - A REVIEW [J].
BIRKEDALHANSEN, H ;
MOORE, WGI ;
BODDEN, MK ;
WINDSOR, LJ ;
BIRKEDALHANSEN, B ;
DECARLO, A ;
ENGLER, JA .
CRITICAL REVIEWS IN ORAL BIOLOGY & MEDICINE, 1993, 4 (02) :197-250
[6]   PHYSIOLOGICAL CONSEQUENCES OF LOSS OF PLASMINOGEN-ACTIVATOR GENE-FUNCTION IN MICE [J].
CARMELIET, P ;
SCHOONJANS, L ;
KIECKENS, L ;
REAM, B ;
DEGEN, J ;
BRONSON, R ;
DEVOS, R ;
VANDENOORD, JJ ;
COLLEN, D ;
MULLIGAN, RC .
NATURE, 1994, 368 (6470) :419-424
[7]  
Damiano BP, 1999, J PHARMACOL EXP THER, V288, P671
[8]   PLASMINOGEN ACTIVATORS, TISSUE DEGRADATION, AND CANCER [J].
DANO, K ;
ANDREASEN, PA ;
GRONDAHLHANSEN, J ;
KRISTENSEN, P ;
NIELSEN, LS ;
SKRIVER, L .
ADVANCES IN CANCER RESEARCH, 1985, 44 :139-266
[9]   THE COAGULATION CASCADE - INITIATION, MAINTENANCE, AND REGULATION [J].
DAVIE, EW ;
FUJIKAWA, K ;
KISIEL, W .
BIOCHEMISTRY, 1991, 30 (43) :10363-10370
[10]   Functional characterization of Kunitz domains in hepatocyte growth factor activator inhibitor type 1 [J].
Denda, K ;
Shimomura, T ;
Kawaguchi, T ;
Miyazawa, K ;
Kitamura, N .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (16) :14053-14059